Marshall Wace
PFE icon

Marshall Wace’s Pfizer PFE Stock Holding History

Marshall Wace’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,000
Closed -$345K – 2719
2023
Q4 		$345K Hold
12,000
– – ﹤0.01% 1846
2023
Q3 		$398K Sell
12,000
-46,500
-79% -$1.64M ﹤0.01% 1789
2023
Q2 		$2.15M Sell
58,500
-175,100
-75% -$6.82M ﹤0.01% 1371
2023
Q1 		$9.53M Buy
233,600
+138,300
+145% +$5.97M 0.02% 732
2022
Q4 		$4.88M Sell
95,300
-259,900
-73% -$12.5M 0.01% 1203
2022
Q3 		$15.5M Buy
355,200
+226,800
+177% +$11M 0.03% 587
2022
Q2 		$6.73M Buy
128,400
+96,400
+301% +$4.91M 0.01% 1143
2022
Q1 		$1.66M Sell
32,000
-208,100
-87% -$10.8M ﹤0.01% 2172
2021
Q4 		$14.2M Buy
+240,100
New +$11.9M 0.03% 640

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Marshall Wace's PFE Position: Q1 2026 in Review

Marshall Wace increased its Pfizer (PFE) stake by 27% in Q1 2026, buying an estimated $91.1M and bringing the position to 16,082,788 shares worth $452M. The position accounts for 0.45% of the portfolio, ranked #22.

Marshall Wace first reported a position in PFE in Q1 2014 and has held it in 42 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Marshall Wace held 16,082,788 shares of Pfizer worth $452M as of Q1 2026.
  • Marshall Wace bought 3,420,874 Pfizer shares in Q1 2026, an estimated $91.1M.
  • Pfizer made up 0.45% of Marshall Wace's portfolio in Q1 2026, its #22 holding.
  • Marshall Wace first reported a position in Pfizer in Q1 2014 and has held it in 42 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.